课题基金 / 基金详情

Calcium release-activated Calcium (CRAC) current: Impact on human B-cell function and its physiological role in human mesothelial cells

Calcium release-activated Calcium (CRAC) current: Impact on human B-cell function and its physiological role in human mesothelial cells
钙释放激活钙 (CRAC) 电流:对人 B 细胞功能及其在人间皮细胞中的生理作用的影响
批准号:
239748479
负责人:
Dr. Tatiana Kilch-Di Rosa
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2013-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Calcium (Ca2+) is an ubiquitous signalling messenger and plays an essential role in every aspect of a cell s life and death. Cells can increase their intracellular Ca2+ concentration either by releasing Ca2+ from intracellular stores or by opening of Ca2+ conducting channels in the plasma membrane (PM), such as the Calcium release-activated calcium channel (CRAC) composed of the channel-forming protein Orai (after keeper of heaven's gate in Greek mythology) and the endoplasmic reticulum (ER) Ca2+ sensor stromal interaction molecule (STIM). Upon store depletion, STIM binds and activates plasma membrane localized Orai channels, providing a Ca2+ influx pathway that is essential for proper cell function in almost all eukaryotic cells. Careful titration of the protein concentration of STIM and Orai thus determines the amount of Ca2+ influx and its subsequent downstream effects e.g. nuclear factor of activated T cells (NFAT) signalling cascades of gene transcription, proapoptotic pathways such as EK signalling or survival pathways such as B/Akt. The channel forming protein Orai exists as the three homologs Orai1, 2 and 3. The calcium sensing protein STIM exists as the two homologs STIM1 and 2. It is already shown that store operated calcium entry (SOCE) plays a crucial role in immune cell function and that dysregulation in this process leads to the development of immunodeficiency, autoimmunity and cancer.While the physiological role of Orai1 was intensively researched within the last years, the impact of Orai2 or Orai3 function in primary cells remains still elusive. Thus, I propose to investigate the physiological role of Orai2 in primary human B-cells and B-cell lines (Daudi, Raji). Human B-cells exhibit a perfect model system for the delineation of the native Orai2 function, expressing remarkable amounts of Orai2 and easy to isolate and to handle. I will characterize the Orai mediated Ca2+ influx with electrophysiological, Fura2-based imaging and silencing approaches and investigate its physiological role regarding the antibody production or the interleukine secretion e.g. IL-10. This part of the project will gain our limited knowledge about Orai2 in general and about CRAC/SOCE in human B-cells (SA 1). Ca2+ signalling and the CRAC current play also a crucial role in my second research project. The TNFalpha and NF-kappaB signalling pathways are both Ca2+ dependent processes. Haining Yang et al. were able to identify the importance of these signalling pathways in the genesis of asbestos-induced mesothelioma, a special form of cancer, which causes ~2.000-3.000 deaths per year in the U.S.. The underlying Ca2+ mobilizing processes are still elusive and in general it is almost nothing known about Ca2+ signalling in human mesothelial cells (HM). So I suggest to characterize SOCE and CRAC in primary human mesothelial cells and to elucidate the contribution of this specific Ca2+ entry pathway to the development of asbestos-induced oncogenesis (SA 2).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
  • 批准号:
    82370921
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    徐袁瑾
  • 依托单位:
Capture and Release of Droplets Using Advanced Materials for High Technology Applications
  • 批准号:
    52073127
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    Alidad Amirfazli
  • 依托单位:
基于目标诱导链释放的高灵敏度信号放大技术的构建及食品中毒素检测研究
  • 批准号:
    21275085
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2012
  • 负责人:
    混旭
  • 依托单位:
长白山垂直带土壤动物多样性及其在凋落物分解和元素释放中的贡献
  • 批准号:
    41171207
  • 项目类别:
    面上项目
  • 资助金额:
    85.0万元
  • 批准年份:
    2011
  • 负责人:
    殷秀琴
  • 依托单位: